OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study.
NCT ID: NCT04074642
Last Updated: 2023-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
21 participants
INTERVENTIONAL
2019-11-14
2023-02-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predictive OCTA Biomarkers After Endoscopic Endonasal Pituitary Surgery
NCT04840771
Evaluation of Early Retinal Vascular Modifications After Endoscopic Endonasal Pituitary Surgery
NCT04425954
"Predicting Glaucoma Progression With Optical Coherence Tomography Structural and Angiographic Parameters".
NCT04646122
Long-term Follow up for Retinal Vascular Changes After Endoscopic Endonasal Pituitary Surgery.
NCT04546386
OCT Angiography in Arteritic and Non Arteritic Anterior Ischemic Neuropathy
NCT03642899
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non compressive adenoma
Optical Coherence Tomography Angiography without surgery
No interventions assigned to this group
Compressive adenoma
Optical Coherence Tomography Angiography before and after neurosurgery
Neurosurgery
adenoma removal
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neurosurgery
adenoma removal
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* pituitary non compressive adenoma
Exclusion Criteria
* amblyopia
* parkinson disease
* pregnant woman
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nice
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ARNAUD MARTEL
Role: PRINCIPAL_INVESTIGATOR
ophtalmology department, Nice University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de NICE
Nice, , France
Hôpital Pasteur 2 - Service d'Ophtalmologie
Nice, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19-AOI-06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.